Zhejiang Chengyi Pharmaceutical Co. Ltd. Class ASSE: 603811

Announcement on the Acquisition of Drug Registration Certificate for Peramivir Injection

· Issued by Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on the Acquisition of Drug Registration Certificate for Peramivir Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment